Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis

Natasha K. Martin*, Peter Vickerman, Iain F. Brew, Joan Williamson, Alec Miners, William L. Irving, Sushma Saksena, Sharon J. Hutchinson, Sema Mandal, Eamonn O'Moore, Mathew Hickman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

46 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences